Minodronic acid monohydrate

CAS No. 155648-60-5

Minodronic acid monohydrate( —— )

Catalog No. M21947 CAS No. 155648-60-5

Minodronic acid monohydrate is an farnesyl diphosphate synthase inhibitor that acts as a bone resorption inhibitor.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 45 In Stock
10MG 68 In Stock
25MG 115 In Stock
50MG 173 In Stock
100MG 258 In Stock
200MG 388 In Stock
500MG 642 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Minodronic acid monohydrate
  • Note
    Research use only, not for human use.
  • Brief Description
    Minodronic acid monohydrate is an farnesyl diphosphate synthase inhibitor that acts as a bone resorption inhibitor.
  • Description
    Minodronic acid monohydrate is an farnesyl diphosphate synthase inhibitor that acts as a bone resorption inhibitor.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Metabolic Enzyme/Protease
  • Target
    Transferase
  • Recptor
    Farnesyl diphosphate synthase
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    155648-60-5
  • Formula Weight
    340.16
  • Molecular Formula
    C9H14N2O8P2
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    O.OC(Cc1cnc2ccccn12)(P(O)(O)=O)P(O)(O)=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Airoldi A , Bettoni P , Donnola M , et al. Crystal structure of zwitterionic 3-(2-hydroxy-2-phosphonato-2-phosphonoethyl)imidazo[1, 2-a]-pyridin-1-ium monohydrate (minodronic acid monohydrate): A redetermination[J]. Acta Crystallogr E Crystallogr Commun, 2015.
molnova catalog
related products
  • SB 271046 hydrochlor...

    SB 271046 hydrochloride is selective, orally active 5-HT6 antagonist.

  • Miglustat hydrochlor...

    Miglustat hydrochloride is an inhibitor of glucosylceramide synthase and can be used for studies about Type I Gaucher disease.

  • GGTI-2133

    GGTI-2133 is a potent mimetic peptidyl geranylgeranyltransferase type I inhibitor (GGTase I) with an IC50 value of 38 nM.GGTI-2133 inhibits the invasion of inflammatory cells into the airways in experimental asthma in mice.